Mary Hill

848 total citations
26 papers, 642 citations indexed

About

Mary Hill is a scholar working on Physiology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mary Hill has authored 26 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Immunology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mary Hill's work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Mary Hill is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Mary Hill collaborates with scholars based in Canada, United States and Poland. Mary Hill's co-authors include Daniel J. Drucker, Patricia L. Brubaker, L. Sylvia, Qing Shi, Martin Sumner-Smith, Anna Crivici, Christopher May, Gordon B. Mills, JoAnne McLaurin and Nan Zhang and has published in prestigious journals such as Nature Biotechnology, Brain and Diabetes.

In The Last Decade

Mary Hill

23 papers receiving 633 citations

Peers

Countries citing papers authored by Mary Hill

Since Specialization

Citations

This map shows the geographic impact of Mary Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Hill more than expected).

Fields of papers citing papers by Mary Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Hill. The network helps show where Mary Hill may publish in the future.

Co-authorship network of co-authors of Mary Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Hill. A scholar is included among the top collaborators of Mary Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Hill. Mary Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deep brain stimulation-induced normalization of hippocampal synchrony in a transgenic rat model of Alzheimer's disease 2025 ·Theranostics ·Andrea Trevisiol, Tina L. Beckett, Miquel Vila, Mary Hill, JoAnne McLaurin, Bojana Stefanovic	0
2	High caloric intake improves neuronal metabolism and functional hyperemia in a rat model of early AD pathology 2024 ·Theranostics ·(unknown), Margaret M. Koletar, Aaron Y. Lai, Wilfred Lam, (unknown), Mary Hill, Greg J. Stanisz, JoAnne McLaurin, Bojana Stefanovic	2
3	Obesity differentially effects the somatosensory cortex and striatum of TgF344-AD rats 2024 ·Scientific Reports ·(unknown), Aaron Y. Lai, Mary Hill, (unknown), (unknown), JoAnne McLaurin	0
4	Sex, gender, and sexuality in paleopathology: Select current developments and pathways forward 2023 ·International Journal of Paleopathology ·Molly K. Zuckerman, (unknown), (unknown), (unknown), (unknown), Mary Hill, (unknown), (unknown), (unknown)	10
5	Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease 2022 ·Translational Neurodegeneration ·(unknown), Aaron Y. Lai, (unknown), Mary Hill, JoAnne McLaurin	22
6	Compromised Cortical-Hippocampal Network Function From Transient Hypertension: Linking Mid-Life Hypertension to Late Life Dementia Risk 2022 ·Frontiers in Neuroscience ·Aaron Y. Lai, Paolo Bazzigaluppi, (unknown), Mary Hill, Bojana Stefanovic, JoAnne McLaurin	1
7	Venular amyloid accumulation in transgenic Fischer 344 Alzheimer’s disease rats 2022 ·Scientific Reports ·(unknown), Tina L. Beckett, Aaron Y. Lai, Mary Hill, Dallan McMahon, JoAnne McLaurin	10
8	Early alterations in brain glucose metabolism and vascular function in a transgenic rat model of Alzheimer’s disease 2022 ·Progress in Neurobiology ·(unknown), Wilfred Lam, Wendy Oakden, Mary Hill, Margaret M. Koletar, (unknown), Greg J. Stanisz, JoAnne McLaurin, Bojana Stefanovic	14
9	Cerebrovascular damage after midlife transient hypertension in non-transgenic and Alzheimer’s disease rats 2021 ·Brain Research ·Aaron Y. Lai, (unknown), (unknown), Adrienne Dorr, Mary Hill, Bojana Stefanovic, JoAnne McLaurin	9
10	Awake two‐photon fluorescence imaging in the TgF344‐AD Alzheimer’s disease rat model 2020 ·Alzheimer s & Dementia ·(unknown), (unknown), Margaret M. Koletar, Mary Hill, (unknown), Bojana Stefanovic, JoAnne McLaurin	1
11	Combinatorial Treatment Using Umbilical Cord Perivascular Cells and Aβ Clearance Rescues Vascular Function Following Transient Hypertension in a Rat Model of Alzheimer Disease 2019 ·Hypertension ·Paolo Bazzigaluppi, Tina L. Beckett, Margaret M. Koletar, Mary Hill, Aaron Y. Lai, (unknown), Lynsie A.M. Thomason, Adrienne Dorr, Denis Gallagher, Clifford Librach, (unknown), JoAnne McLaurin, Bojana Stefanovic	10
12	Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. 2000 ·Diabetes ·Louise A. Scrocchi, Mary Hill, Jumana Saleh, Bruce A. Perkins, Daniel J. Drucker	46
13	Biologic Properties and Therapeutic Potential of Glucagon‐like Peptide‐2 1999 ·Journal of Parenteral and Enteral Nutrition ·Daniel J. Drucker, Robin P. Boushey, (unknown), Mary Hill, Patricia L. Brubaker, Bernardo Yusta	20
14	Human hematopoietic cells express two forms of the cytokine receptor common γ-chain (γc) 1997 ·Cell Research ·Yufang Shi, Mary Hill, Anton Novak, (unknown), (unknown), Choong Chin Liew, Gordon B. Mills	2
15	Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV 1997 ·Nature Biotechnology ·Daniel J. Drucker, Qing Shi, Anna Crivici, Martin Sumner-Smith, (unknown), Mary Hill, (unknown), (unknown), Patricia L. Brubaker	218
16	Transmembrane signaling by the interleukin-2 receptor: progress and conundrums 1993 ·Seminars in Immunology ·Gordon B. Mills, Rosemarie Schmandt, Spencer B. Gibson, Bernadine Leung, Mary Hill, Chris May, Yufang Shi, Donald R. Branch, Laszlo Radvanyi, Kenneth E. Truitt, John B. Imboden	28
17	Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-l-infected human T cells 1992 ·International Immunology ·Gordon B. Mills, Naomichi Arima, Christopher May, Mary Hill, Rosemarie Schmandt, Jun Li, (unknown), Warner C. Greene	29
18	Interrelationship between signals transduced by phytohemagglutinin and interleukin 1 1990 ·Journal of Cellular Physiology ·Gordon B. Mills, Mary Hill, (unknown), Christopher May, (unknown), David J. Stewart, Alan Mellors, Erwin W. Gelfand	11
19	Role of protein kinase c in interleukin 1, anti‐T3, and mitogenic lectin‐induced interleukin 2 secretion 1989 ·Journal of Cellular Physiology ·G B Mills, Christopher May, Mary Hill, Erwin W. Gelfand	10
20	An Atherosclerosis Risk Factor Assessment Program for Patients with Peripheral Arterial Occlusive Disease 1988 ·Annals of Vascular Surgery ·K.W. Johnston, (unknown), George Steiner, P Kálmán, Leonard Schwartz, Mary Hill, Paul M. Walker	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact